Skip to product information
1 of 1

Merck Animal Health

Bovilis J-5-50 Dose

Bovilis J-5-50 Dose

Regular price $82.95 USD
Regular price Sale price $82.95 USD
Sale Sold out

Size: 50 Dose 

For the vaccination of healthy dairy cows and heifers as an aid in reducing coliform mastitis due to Escherichia coli bacteria. This killed vaccine; contains cultures of the J-5 strain of Escherichia coli bacteria. Unvaccinated animals contracting coliform mastitis may experience abortions, loss of milk production in the affected quarter and it can be life threating. Formulated with high antigen content and quality for maximum effectiveness. Gram-negative infections from bacteria like Escherichia coli cause mastitis that leads to milk loss, culling and death. BOVILIS J-5 is a Gram-negative core-antigen vaccine that aids in the reduction of mastitis due to E. coli – with the lowest level of endotoxins to minimize potential side effects.

Bovilis J-5 is low in endotoxin and the only brand with the endotoxin level printed on the bottle to assure you of the product safety sheet. This product is intended for use in healthy dairy cattle as an aid in the reduction of mastitis due to Escherichia coli. To use, shake well and administer a 5 mL dose SQ. Three doses are recommended at four to six week intervals. Do not vaccinate within 2 weeks of parturition.

Cows: Administer 5 ml SubQ. Three doses are recommended at four to six week intervals. Do not vaccinate within two weeks of parturition.

Manufacturer and/or Label Information

MERCK ANIMAL HEALTH
Intervet Inc.
2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service: 800-521-5767
Order Desk: 800-648-2118
Technical Service (Companion Animal): 800-224-5318
Technical Service (Livestock): 800-211-3573
Fax: 973-937-5557
Website: www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
BOVILIS® J-5

Intervet/Merck Animal Health

Escherichia Coli Bacterin

This product has been shown to be effective for vaccination of healthy adult cattle, including pregnant cattle, against mastitis due to Escherichia coli. Duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

To use, shake well and administer a 5mL dose subcutaneously. Three doses are recommended at four to six week intervals. Do not vaccinate within two weeks of parturition.

PRECAUTIONS: For animal use only. Safe for use in pregnant cattle. Do not mix with other products. Do not vaccinate within 60 days of slaughter. Entire contents of this bottle should be used when first opened. If an anaphylactic reaction occurs, appropriate therapy with epinephrine should be instituted immediately. Any adverse reactions following vaccination should be reported to the manufacturer.

WARNING: This product contains oil adjuvant. Contains thimerosal as a preservative.

In case of human exposure, contact a physician.

Store at 2° to 8°C (35° to 45°F); DO NOT FREEZE.

SHAKE WELL BEFORE USING.

Manufactured by:

Hygieia Biological Laboratories, Woodland, CA 95776

VLN 407/PCN 2648.00

1 530 661-1442

Distributed by:

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103 USA

1 800 521-5767







Code



250 mL

50 doses

5 mL per dose

159322

383144 R4

CPN: 1047522.1

COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details